Cell-based therapies for Parkinson's disease

Expert Review of Neurotherapeutics

Volumn 11, Issue 6, 2011, Pages 831-844

  Dyson, Sean C ^a   Barker, Roger A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

cell therapy; dopaminergic neuron; induced neuronal cell; induced pluripotent stem cell; Parkinson's disease; stem cell; transplantation; ventral mesencephalon

Indexed keywords

18 FLUORINE DOPAMINE; ALPHA GALACTOSYLCERAMIDE; BUSPIRONE; DOPAMINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 8; FLUORINE 18; KRUPPEL LIKE FACTOR 4; NUCLEAR RECEPTOR RELATED FACTOR 1; OCTAMER TRANSCRIPTION FACTOR 4; OXIDOPAMINE; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PROTEIN BCL XL; SEROTONIN; TRANSCRIPTION FACTOR SOX2; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; WNT1 PROTEIN;

ADRENAL MEDULLA; ADVERSE OUTCOME; BRAIN DEPTH STIMULATION; CARCINOGENICITY; CAROTID BODY; CELL BASED GENE THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DOPAMINERGIC NERVE CELL; DYSKINESIA; EMBRYONIC STEM CELL; FETAL TISSUE TRANSPLANTATION; FLUORESCENCE ACTIVATED CELL SORTER; GRAFT INDUCED DYSKINESIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MESENCEPHALON; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; ONCOGENE C MYC; PARKINSON DISEASE; PARKINSONISM; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; REVIEW; VIRAL GENE DELIVERY SYSTEM; XENOTRANSPLANTATION;

ANIMALS; HUMANS; NEURAL STEM CELLS; PARKINSON DISEASE; STEM CELL TRANSPLANTATION;

EID: 79958279109     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.33     Document Type: Review

References (165)

1. Parkinson J. An essay on the shaking palsy. J. Neuropsychiatry Clin. Neurosci. 14(2), 223-236 (2002).
2. Owen AM. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist 10(6), 525-537 (2004). (Pubitemid 39546395)
3. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García- Sánchez C, Gironell A. Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov. Disord. 23(13), 1889-1896 (2008).
4. Lees AJ, Selikhova M, Andrade LA, Duyckaerts C. The black stuff and Konstantin Nikolaevich Tretiakoff. Mov. Disord. 23(6), 777-783 (2008).
5. Hornykiewicz O. The discovery of dopamine deficiency in the Parkinsonian brain. In: Parkinson's Disease and Related Disorders. Riederer P, Reichmann H, Youdim MBH, Gerlach M (Eds). Springer, Vienna, Austria, 9-15 (2006). (Pubitemid 44622172)
6. Carlsson A, Lindqvist M, Magnusson TOR. 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180(4596), 1200 (1957).
7. Rosegay H. An experimental investigation of the connections between the corpus striatum and substantia nigra in the cat. J. Comp. Neurol. 80(3), 293-321 (1944).
8. Andén NE, Carlsson A, Dahlström A, Fuxe K, Hillarp NÅ, Larsson K. Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3(6), 523-530 (1964).
9. Andén NE, Dahlström A, Fuxe K, Larsson K. Further evidence for the presence of nigro-neostriatal dopamine neurons in the rat. Am. J. Anat. 116(1), 329-333 (1965).
10. Lim SY, Lang AE. The nonmotor symptoms of Parkinson's disease - an overview. Mov. Disord. 25(S1), S123-S130 (2010).
11. Lauder JM, Bloom FE. Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. J. Comp. Neurol. 163(3), 251-264 (1975).
12. Specht LA, Pickel VM, Joh TH, Reis DJ. Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. II. Late ontogeny. J. Comp. Neurol. 199(2), 255-276 (1981). (Pubitemid 11122896)
13. Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204(4393), 643-647 (1979). (Pubitemid 9221523)
14. Björklund A, Stenevi U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177(3), 555-560 (1979). (Pubitemid 10241286)
15. Björklund A, Schmidt RH, Stenevi U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res. 212(1), 39-45 (1980). (Pubitemid 11222663)
16. Madrazo I, Leon V, Torres C, et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. N. Engl. J. Med. 318(1), 51 (1988). (Pubitemid 18025482)
17. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46(6), 615-631 (1989). (Pubitemid 19150940)
18. Lindvall O, Gustavii B, Åstedt B, et al. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 332(8626-8627), 1483-1484 (1988). (Pubitemid 19016664)
19. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247(4942), 574-577 (1990).
20. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35(2), 172-180 (1994). (Pubitemid 24050152)
21. Piccini P, Pavese N, Hagell P, et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 128(12), 2977-2986 (2005). (Pubitemid 41746650)
22. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344(10), 710-719 (2001). (Pubitemid 32204988)
23. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol. 54(3), 403-414 (2003). (Pubitemid 37072046)
24. Ma Y, Tang C, Chaly T, et al. Dopamine cell implantation in Parkinson's disease: long-term clinical and 18F-FDOPA PET outcomes. J. Nucl. Med. 51(1), 7-15 (2010).
25. Hagell P, Schrag A, Piccini P, et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122(6), 1121-1132 (1999). (Pubitemid 29533127)
26. Brundin P, Pogarell O, Hagell P, et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123(7), 1380-1390 (2000). (Pubitemid 30420938)
27. Polgar S, Morris ME, Reilly S, Bilney B, Sanberg PR. Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis. Brain Res. Bull. 60(1-2), 1-24 (2003). (Pubitemid 36506449)
28. Graff-Radford J, Foote KD, Rodriguez RL, et al. Deep brain stimulation of the internal segment of the globus pallidus in delayed runaway dyskinesia. Arch. Neurol. 63(8), 1181-1184 (2006). (Pubitemid 44232329)
29. Herzog J, Pogarell O, Pinsker MO, et al. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation. Mov. Disord. 23(9), 1293-1296 (2008).
30. Carlsson T, Carta M, Munoz A, et al. Impact of grafted serotonin and dopamine neurons on development of l-dopa-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration. Brain 132(2), 319-335 (2009).
31. Politis M, Wu K, Loane C, et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci. Transl. Med. 2(38), 38ra46 (2010).
32. Barker RA, Kuan W-L. Graft-induced dyskinesias in Parkinson's disease: what is it all about? Cell Stem Cell 7(2), 148-149 (2010).
33. Ma Y, Feigin A, Dhawan V, et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann. Neurol. 52(5), 628-634 (2002). (Pubitemid 35246867)
34. Maries E, Kordower JH, Chu Y, et al. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol. Dis. 21(1), 165-180 (2006). (Pubitemid 41817316)
35. Carlsson T, Winkler C, Lundblad M, Cenci MA, Björklund A, Kirik D. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol. Dis. 21(3), 657-668 (2006). (Pubitemid 43277547)
36. Wurtman RJ, Pohorecky LA, Baliga BS. Adrenocortical control of the biosynthesis of epinephrine and proteins in the adrenal medulla. Pharmacol. Rev. 24(2), 411-426 (1972).
37. Freed WJ, Morihisa JM, Spoor E, et al. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour. Nature 292(5821), 351-352 (1981). (Pubitemid 11050339)
38. Backlund E-O, Granberg P-O, Hamberger B, et al. Transplantation of adrenal medullary tissue to striatum in Parkinsonism. J. Neurosurg. 62(2), 169-173 (1985). (Pubitemid 15159941)
39. Madrazo I, Drucker-Colín R, Díaz V, Martínez-Mata J, Torres C, Becerril JJ. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 316(14), 831-834 (1987). (Pubitemid 17042000)
40. Goetz CG, Stebbins GT, Klawans HL, et al. United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants. Neurology 41(11), 1719 (1991).
41. Hurtig H, Joyce J, Sladek JR, Trojanowski JQ. Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. Ann. Neurol. 25(6), 607-614 (1989). (Pubitemid 19153869)
42. Date I, Asari S, Ohmoto T. Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report. Neurosurgery 37(3), 515-519 (1995).
43. Watts RL, Subramanian T, Freeman A, et al. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson's disease: two-year follow-up study. Exp. Neurol. 147(2), 510-517 (1997). (Pubitemid 27497312)
44. López-Lozano JJ, Bravo G, Abascal J, Brera B, Millan I. Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. J. Neurosurg. 90(5), 875-882 (1999). (Pubitemid 29200682)
45. Olson L, Backlund E-O, Ebendal T, et al. Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease: one-year follow-up of first clinical trial. Arch. Neurol. 48(4), 373-381 (1991).
46. Weir EK, López-Barneo J, Buckler KJ, Archer SL. Acute oxygen-sensing mechanisms. N. Engl. J. Med. 353(19), 2042-2055 (2005).
47. Lopez-Barneo J, Lopez-Lopez J, Urena J, Gonzalez C. Chemotransduction in the carotid body: K+ current modulated by PO2 in type I chemoreceptor cells. Science 241(4865), 580-582 (1988).
48. Ureña J, Fernández-Chacón R, Benot AR, Alvarez de Toledo GA, López-Barneo J. Hypoxia induces voltage-dependent Ca2+ entry and quantal dopamine secretion in carotid body glomus cells. Proc. Natl Acad. Sci. USA 91(21), 10208-10211 (1994).
49. Nosrat CA, Tomac A, Lindqvist E, et al. Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res. 286(2), 191-207 (1996). (Pubitemid 26383666)
50. Villadiego J, Mendez-Ferrer S, Valdes- Sanchez T, et al. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J. Neurosci. 25(16), 4091-4098 (2005). (Pubitemid 40563384)
51. Lin L, Doherty D, Lile J, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260(5111), 1130-1132 (1993). (Pubitemid 23186789)
52. Sinclair SR, Svendsen CN, Torres EM, Martin D, Fawcett JW, Dunnett SB. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport 7(15-17), 2547-2552 (1996). (Pubitemid 26403014)
53. Pardal R, Ortega-Sáenz P, Durán R, López-Barneo J. Glia-like stem cells sustain physiologic neurogenesis in the adult mammalian carotid body. Cell 131(2), 364-377 (2007). (Pubitemid 47576136)
54. Espejo EF, Montoro RJ, Armengol JA, López-Barneo J. Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 20(2), 197-206 (1998). (Pubitemid 28125065)
55. Toledo-Aral JJ, Mendez-Ferrer S, Pardal R, Echevarria M, Lopez-Barneo J. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted Parkinsonian rats. J. Neurosci. 23(1), 141-148 (2003). (Pubitemid 36050413)
56. Luquin MR, Montoro RJ, Guillén J, et al. Recovery of chronic Parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 22(4), 743-750 (1999). (Pubitemid 29203497)
57. Mínguez-Castellanos A, Escamilla-Sevilla F, Hotton GR, et al. Carotid body autotransplantation in Parkinson disease: a clinical and positron emission tomography study. J. Neurol. Neurosurg. Psychiatry 78(8), 825-831 (2007). (Pubitemid 47204586)
58. Galpern WR, Burns LH, Deacon TW, Dinsmore J, Isacson O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of parkinson's disease: functional recovery and graft morphology. Exp. Neurol. 140(1), 1-13 (1996). (Pubitemid 26266588)
59. Barker RA, Ratcliffe E, McLaughlin M, Richards A, Dunnett SB. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease. J. Neurosci. 20(9), 3415-3424 (2000). (Pubitemid 30263157)
60. Isacson O, Deacon TW, Pakzaban P, Galpern WR, Dinsmore J, Burns LH. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat. Med. 1(11), 1189-1194 (1995).
61. Kuan W-L, Hurelbrink CB, Barker RA. Increased capacity for axonal outgrowth using xenogenic tissue in vitro and in a rodent model of Parkinson's disease. Xenotransplantation 13(3), 233-247 (2006). (Pubitemid 43824213)
62. Sumitran S, Liu J, Czech KA, Christensson B, Widner H, Holgersson J. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Gala1, 3Gal-based xenoantigens. Exp. Neurol. 159(2), 347-361 (1999). (Pubitemid 29485222)
63. Harrower TP, Richards A, Cruz G, Copeman L, Dunnett SB, Barker RA. a Gal is widely expressed in embryonic porcine stem cells and neural tissue. NeuroReport 13(4), 481-485 (2002). (Pubitemid 34293195)
64. Phelps CJ, Koike C, Vaught TD, et al. Production of a1,3- galactosyltransferase-deficient pigs. Science 299(5605), 411-414 (2003).
65. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3(3), 282-286 (1997). (Pubitemid 27112924)
66. Björklund A, Dunnett SB, Brundin P, et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. 2(7), 437-445 (2003). (Pubitemid 36793939)
67. Schumacher JM, Ellias SA, Palmer EP, et al. Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54(5), 1042-1050 (2000). (Pubitemid 30151843)
68. Deacon T, Schumacher J, Dinsmore J, et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med. 3(3), 350-353 (1997). (Pubitemid 27112937)
69. Altman J, Bayer SA. Development of the brain stem in the rat. V. Thymidine-radiographic study of the time of origin of neurons in the midbrain tegmentum. J. Comp. Neurol. 198(4), 677-716 (1981). (Pubitemid 11109559)
70. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255(5052), 1707-1710 (1992).
71. Svendsen CN, Caldwell MA, Shen J, et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp. Neurol. 148(1), 135-146 (1997). (Pubitemid 127445121)
72. Studer L, Tabar V, McKay R. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1(4), 290-295 (1998).
73. Yan J, Studer L, McKay RDG. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J. Neurochem. 76(1), 307-311 (2001). (Pubitemid 32044392)
74. Sánchez-Pernaute R, Studer L, Bankiewicz KS, Major EO, McKay RD. In vitro generation and transplantation of precursor-derived human dopamine neurons. J. Neurosci. Res. 65(4), 284-288 (2001). (Pubitemid 32727029)
75. Prakash N, Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell. Mol. Life Sci. 63(2), 187-206 (2006). (Pubitemid 43100289)
76. Smidt MP, Burbach JPH. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 8(1), 21-32 (2007). (Pubitemid 46011996)
77. Hynes M, Poulsen K, Tessier-Lavigne M, Rosenthal A. Control of neuronal diversity by the floor plate: contact-mediated induction of midbrain dopaminergic neurons. Cell 80(1), 95-101 (1995).
78. Wang MZ, Jin P, Bumcrot DA, Marigo V, et al. Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat. Med. 1(11), 1184-1188 (1995).
79. Ye W, Shimamura K, Rubenstein JLR, Hynes MA, Rosenthal A. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93(5), 755-766 (1998). (Pubitemid 28257582)
80. Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet. 18(2), 136-141 (1998). (Pubitemid 28082459)
81. Smidt MP, van Schaick HSA, Lancôt C, et al. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl Acad. Sci. USA 94(24), 13305-13310 (1997). (Pubitemid 27518517)
82. Zetterström RH, Solomin L, Jansson L, Hoffer BJ, Olson L, Perlmann T. Dopamine neuron agenesis in Nurr1- deficient mice. Science 276(5310), 248-250 (1997). (Pubitemid 27172681)
83. Saucedo-Cardenas O, Quintana-Hau JD, Le W-D, et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl Acad. Sci. USA 95(7), 4013-4018 (1998). (Pubitemid 28173245)
84. O'Keeffe FE, Scott SA, Tyers P, et al. Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease. Brain 131(3), 630-641 (2008). (Pubitemid 351294721)
85. Parish CL, Castelo-Branco G, Rawal N, et al. Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. J. Clin. Invest. 118(1), 149-160 (2008).
86. Andersson EKI, Irvin DK, Ahlsiö J, Parmar M. Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells. Exp. Cell Res. 313(6), 1172-1180 (2007). (Pubitemid 46427811)
87. Studer L, Csete M, Lee S-H, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20(19), 7377-7383 (2000).
88. Krabbe C, Courtois E, Jensen P, et al. Enhanced dopaminergic differentiation of human neural stem cells by synergistic effect of Bcl-xL and reduced oxygen tension. J. Neurochem. 110(6), 1908-1920 (2009).
89. Ling ZD, Potter ED, Lipton JW, Carvey PM. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp. Neurol. 149(2), 411-423 (1998). (Pubitemid 28115079)
90. Potter ED, Ling ZD, Carvey PM. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res. 296(2), 235-246 (1999). (Pubitemid 29219176)
91. Carvey PM, Ling ZD, Sortwell CE, et al. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp. Neurol. 171(1), 98-108 (2001). (Pubitemid 32848448)
92. Courtois ET, Castillo CG, Seiz EG, et al. In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-xL. J. Biol. Chem. 285(13), 9881-9897 (2010).
93. Young A, Assey KS, Sturkie CD, West FD, Machacek DW, Stice SL. Glial cell line-derived neurotrophic factor enhances in vitro differentiation of mid-/hindbrain neural progenitor cells to dopaminergic-like neurons. J. Neurosci. Res. 88(15), 3222-3232 (2010).
94. Rößler R, Boddeke E, Copray S. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. Neuroscience 170(2), 417-428 (2010).
95. Donaldson AE, Marshall CE, Yang M, Suon S, Iacovitti L. Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture. Mol. Cell. Neurosci. 30(1), 108-117 (2005). (Pubitemid 41133344)
96. Hedlund E, Pruszak J, Lardaro T, et al. Embryonic stem cell-derived Pitx3- enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 26(6), 1526-1536 (2008).
97. Jain M, Armstrong RJE, Tyers P, Barker RA, Rosser AE. GABAergic immunoreactivity is predominant in neurons derived from expanded human neural precursor cells in vitro. Exp. Neurol. 182(1), 113-123 (2003). (Pubitemid 36776254)
98. Chung S, Shin BS, Hwang M, et al. Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells 24(6), 1583-1593 (2006). (Pubitemid 44464676)
99. Jensen P, Pedersen EG, Zimmer J, Widmer HR, Meyer M. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease. Brain Res. 1218, 13-20 (2008).
100. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819), 154-156 (1981). (Pubitemid 11050741)
101. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78(12), 7634-7638 (1981). (Pubitemid 12186197)
102. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc. Natl Acad. Sci. USA 92(17), 7844-7848 (1995).
103. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145-1147 (1998). (Pubitemid 28516247)
104. Park S, Lee KS, Lee YJ, et al. Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors. Neurosci. Lett. 359(1-2), 99-103 (2004). (Pubitemid 38446648)
105. Perrier AL, Tabar V, Barberi T, et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 101(34), 12543-12548 (2004). (Pubitemid 39122060)
106. Lee S-H, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotech. 18(6), 675-679 (2000). (Pubitemid 30415305)
107. Cho MS, Lee Y-E, Kim JY, et al. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc. Natl Acad. Sci. USA 105(9), 3392-3397 (2008). (Pubitemid 351723563)
108. Cho M-S, Hwang D-Y, Kim D-W. Efficient derivation of functional dopaminergic neurons from human embryonic stem cells on a large scale. Nat. Protocols 3(12), 1888-1894 (2008).
109. Kim J-H, Auerbach JM, Rodriguez-Gomez JA, et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418(6893), 50-56 (2002). (Pubitemid 34742566)
110. Zhang Z-J, Yang D, Oldenburg M, Ayala M, Zhang S-C. Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in Parkinsonian rats. Stem Cells 26(1), 55-63 (2008).
111. Ben-Hur T, Idelson M, Khaner H, et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in parkinsonian rats. Stem Cells 22(7), 1246-1255 (2004). (Pubitemid 39636402)
112. Brederlau A, Correia AS, Anisimov SV, et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24(6), 1433-1440 (2006). (Pubitemid 44464659)
113. Kim D, Kim C-H, Moon J-I, Chung Y-G, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6), 472-476 (2009).
114. Jönsson ME, Ono Y, Björklund A, Thompson LH. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp. Neurol. 219(1), 341-354 (2009).
115. Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227(2), 271-278 (2000).
116. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61(4), 364-370 (2000). (Pubitemid 30620221)
117. Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J. Neurosci. Res. 69(6), 908-917 (2002). (Pubitemid 34984707)
118. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164(2), 247-256 (2000). (Pubitemid 32008970)
119. Munoz-Elias G, Marcus AJ, Coyne TM, Woodbury D, Black IB. Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J. Neurosci. 24(19), 4585-4595 (2004). (Pubitemid 38656614)
120. Li Y, Chen J, Wang L, Zhang L, Lu M, Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci. Lett. 316(2), 67-70 (2001). (Pubitemid 34001662)
121. Dezawa M, Kanno H, Hoshino M, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113(12), 1701-1710 (2004). (Pubitemid 39071662)
122. Offen D, Barhum Y, Levy YS, et al. Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease. In: Neuropsychiatric Disorders: An Integrative Approach. Gerlach M, Deckert J, Double K, Koutsilieri E (Eds). Springer, Vienna, Austria, 133-143 (2007).
123. Jin G-Z, Cho S-J, Choi E-G, et al. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro. Cell Biol. Int. 32(11), 1433-1438 (2008).
124. Bouchez G, Sensebé L, Vourc'h P, et al. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem. Int. 52(7), 1332-1342 (2008).
125. Fumagalli F, Racagni G, Riva MA. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J. 6(2), 95-104 (2006).
126. Björklund A, Rosenblad C, Winkler C, Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4(3-4), 186-200 (1997). (Pubitemid 27465509)
127. Wang F, Yasuhara T, Shingo T, et al. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1a. BMC Neurosci. 11(1), 52 (2010).
128. Venkataramana NK, Kumar SKV, Balaraju S, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl. Res. 155(2), 62-70 (2010).
129. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006). (Pubitemid 44233629)
130. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17(1), 126-140 (2003). (Pubitemid 36062514)
131. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3), 379-391 (1998). (Pubitemid 28507326)
132. Niwa H, Miyazaki J-I, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24(4), 372-376 (2000). (Pubitemid 30187435)
133. Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC, Chan RJ. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105(2), 635-637 (2005). (Pubitemid 40070746)
134. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007). (Pubitemid 350138099)
135. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917-1920 (2007).
136. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without myc from mouse and human fibroblasts. Nat. Biotech. 26(1), 101-106 (2008).
137. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136(5), 964-977 (2009).
138. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458(7239), 771-775 (2009).
139. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 322(5903), 945-949 (2008).
140. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322(5903), 949-953 (2008).
141. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458(7239), 766-770 (2009).
142. Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 4(5), 381-384 (2009).
143. Jia F, Wilson KD, Sun N, et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7(3), 197-199 (2010).
144. Wernig M, Zhao J-P, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105(15), 5856-5861 (2008). (Pubitemid 351758462)
145. Swistowski A, Peng J, Liu Q, et al. Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under def?ined conditions. Stem Cells 28(10), 1893-1904 (2010).
146. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells Dev. 19(7), 1017-1023 (2010).
147. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. 136(5), 964-977 (2009).
148. Hargus G, Cooper O, Deleidi M, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl Acad. Sci. USA 107(36), 15921-15926 (2010).
149. Park I-H, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell 134(5), 877-886 (2008).
150. Urnov FD, Miller JC, Lee Y-L, et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435(7042), 646-651 (2005). (Pubitemid 40825505)
151. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463(7284), 1035-1041 (2010).
152. Schultzberg M, Dunnett SB, Björklund A, et al. Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: evidence for selective growth regulation. Neuroscience 12(1), 17-32 (1984). (Pubitemid 14077674)
153. Grealish S, Jonsson ME, Li M, Kirik D, Bjorklund A, Thompson LH. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 133(2), 482-495 (2010).
154. Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 350(9092), 1675 (1997). (Pubitemid 28036830)
155. Vingerhoets FJG, Villemure J-G, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease. Neurology 58(3), 396-401 (2002). (Pubitemid 34150913)
156. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 349(20), 1925-1934 (2003). (Pubitemid 37409709)
157. Le Jeune F, Drapier D, Bourguignon A, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy. Neurology 73(21), 1746-1751 (2009).
158. Hershey T, Revilla FJ, Wernle A, Gibson PS, Dowling JL, Perlmutter JS. Stimulation of STN impairs aspects of cognitive control in PD. Neurology 62(7), 1110-1114 (2004). (Pubitemid 38456504)
159. Mallet L, Schüpbach M, N'Diaye K, et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc. Natl Acad. Sci. USA 104(25), 10661-10666 (2007). (Pubitemid 47185721)
160. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131(10), 2720-2728 (2008).
161. Li J-Y, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14(5), 501-503 (2008). (Pubitemid 351655211)
162. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14(5), 504-506 (2008). (Pubitemid 351655212)
163. Mendez I, Vinuela A, Astradsson A, et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med. 14(5), 507-509 (2008). (Pubitemid 351655215)
164. Anderson L, Caldwell MA. Human neural progenitor cell transplants into the subthalamic nucleus lead to functional recovery in a rat model of Parkinson's disease. Neurobiol. Dis. 27(2), 133-140 (2007). (Pubitemid 47088975)
165. TRANSEURO www.transeuro.org.uk